Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 1 |
2019 | 1 |
2021 | 1 |
2024 | 1 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Fatal and Nonfatal Events Within 14 days After Early, Intensive Mobilization Poststroke.
Neurology. 2021 Feb 22;96(8):e1156-e1166. doi: 10.1212/WNL.0000000000011106.
Neurology. 2021.
PMID: 33144512
Free PMC article.
Performance Evaluation of a Thermophilic Anaerobic Membrane Bioreactor for Palm Oil Wastewater Treatment.
Yee TL, Rathnayake T, Visvanathan C.
Yee TL, et al.
Membranes (Basel). 2019 Apr 18;9(4):55. doi: 10.3390/membranes9040055.
Membranes (Basel). 2019.
PMID: 31003466
Free PMC article.
The reactor was operated at Organic Loading Rates (OLR) of 2, 3, 4, 6, 8, and 10 kg Chemical Oxygen Demand (COD)/m(3).d to investigate the treatment performance and the membrane operation. The efficiency of the COD removal achieved by the system was between 93-98%. …
The reactor was operated at Organic Loading Rates (OLR) of 2, 3, 4, 6, 8, and 10 kg Chemical Oxygen Demand (COD)/m(3).d to inv …
Item in Clipboard
Prespecified dose-response analysis for A Very Early Rehabilitation Trial (AVERT).
Bernhardt J, Churilov L, Ellery F, Collier J, Chamberlain J, Langhorne P, Lindley RI, Moodie M, Dewey H, Thrift AG, Donnan G; AVERT Collaboration Group.
Bernhardt J, et al.
Neurology. 2016 Jun 7;86(23):2138-45. doi: 10.1212/WNL.0000000000002459. Epub 2016 Feb 17.
Neurology. 2016.
PMID: 26888985
Free PMC article.
Clinical Trial.
Item in Clipboard
Discovery and Characterization of VU0542270, the First Selective Inhibitor of Vascular Kir6.1/SUR2B KATP Channels.
Li K, McClenahan SJ, Han C, Bungard JD, Rathnayake U, Boutaud O, Bauer JA, Days EL, Lindsley CW, Shelton EL, Denton JS.
Li K, et al.
Mol Pharmacol. 2024 Feb 15;105(3):202-212. doi: 10.1124/molpharm.123.000783.
Mol Pharmacol. 2024.
PMID: 38302135
Free PMC article.
VU0542270 inhibits Kir6.1/SUR2B with an IC(50) of approximately 100 nM but has no apparent activity toward Kir6.2/SUR1 or several other members of the Kir channel family at doses up to 30 M (>300-fold selectivity). By expressing different combinations of Kir6.1 or Kir6. …
VU0542270 inhibits Kir6.1/SUR2B with an IC(50) of approximately 100 nM but has no apparent activity toward Kir6.2/SUR1 or several other memb …
Item in Clipboard
Cite
Cite